- Home
- ELF vs VRNA Comparison
ELF vs VRNA Comparison
Compare ELF & VRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELF
- VRNA
- Stock Information
- Founded
- ELF 2004
- VRNA 2005
- Country
- ELF United States
- VRNA United Kingdom
- Employees
- ELF N/A
- VRNA N/A
- Industry
- ELF Package Goods/Cosmetics
- VRNA Biotechnology: Pharmaceutical Preparations
- Sector
- ELF Consumer Discretionary
- VRNA Health Care
- Exchange
- ELF Nasdaq
- VRNA Nasdaq
- Market Cap
- ELF 6.9B
- VRNA 8.3B
- IPO Year
- ELF 2016
- VRNA 2017
- Fundamental
- Price
- ELF $110.57
- VRNA $104.83
- Analyst Decision
- ELF Buy
- VRNA Buy
- Analyst Count
- ELF 16
- VRNA 11
- Target Price
- ELF $121.44
- VRNA $112.40
- AVG Volume (30 Days)
- ELF 1.9M
- VRNA 5.5M
- Earning Date
- ELF 08-07-2025
- VRNA 08-07-2025
- Dividend Yield
- ELF N/A
- VRNA N/A
- EPS Growth
- ELF N/A
- VRNA N/A
- EPS
- ELF 1.92
- VRNA N/A
- Revenue
- ELF $1,313,517,000.00
- VRNA $118,535,000.00
- Revenue This Year
- ELF $22.42
- VRNA $891.79
- Revenue Next Year
- ELF $15.80
- VRNA $78.94
- P/E Ratio
- ELF $57.28
- VRNA N/A
- Revenue Growth
- ELF 28.28
- VRNA N/A
- 52 Week Low
- ELF $49.40
- VRNA $17.96
- 52 Week High
- ELF $219.77
- VRNA $104.99
- Technical
- Relative Strength Index (RSI)
- ELF 42.65
- VRNA 70.87
- Support Level
- ELF $113.88
- VRNA $86.63
- Resistance Level
- ELF $132.48
- VRNA $104.99
- Average True Range (ATR)
- ELF 5.17
- VRNA 2.73
- MACD
- ELF -3.21
- VRNA 0.50
- Stochastic Oscillator
- ELF 0.32
- VRNA 99.24
About ELF e.l.f. Beauty Inc.
e.l.f. Beauty Inc is a multi-brand beauty company that offers inclusive, accessible, clean, vegan, and cruelty-free cosmetics and skin care products. The Company's mission is to make beauty accessible to every eye, lip, face, and skin concern. The company offers cosmetic accessories for women, which include eyeliner, mascara, false eyelashes, lipstick, foundation for the face, moisturizer, cleanser, and other tools through its stores and e-commerce channels.
About VRNA Verona Pharma plc
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.